Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
09/2005
09/01/2005WO2005079378A2 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto
09/01/2005US20050192275 3-(substituted phenyl)-5-substituted-oxazolidin-2-ones; tuberculosis; e.g. (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]-4-oxo-4-phenylbutanamide
09/01/2005DE102004008141A1 Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren Guanidine compounds and their use as binding partners for 5-HT5 receptors
09/01/2005CA2555970A1 Therapeutic amide derivatives
09/01/2005CA2554774A1 Novel heterocyclic compound
09/01/2005CA2554686A1 Compounds
09/01/2005CA2537079A1 Fluorene derivative
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1568701A1 Transition metal complex having diphosphine complex as ligand
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568696A1 Compounds as inhibitors of cell proliferation and viral infections
08/31/2005EP1568693A1 Process for producing quinolinecarbaldehyde
08/31/2005EP1567525A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662510A Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives
08/31/2005CN1662484A Process for preparing (r)-aryloxypropionic acid ester derivatives
08/31/2005CN1662215A Benzoxazole and benzodiazole UV-A sunscreens
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
08/30/2005US6936638 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy
08/30/2005US6936630 Sulfur compounds such as 1-(5-chloro-2-methyl-phenyl)-3-(3-methyl-isothiazol-5-yl)-thiourea, used for prophylaxis of cardiovascular disorders
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005063724B1 1-(azolin-2-yl) amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes
08/25/2005WO2004069394A3 Synthetic method for direct arylation of heterocyclic arenes
08/25/2005US20050187274 One pot synthesis of 2-oxazolidinone derivatives
08/25/2005US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/24/2005EP1565186A1 N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
08/24/2005EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
08/24/2005EP1263742B1 Oxazolidinone thioamides with piperazine amide substituents
08/24/2005EP1144394B1 1-heterocycle substituted diarylamines
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659268A Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1216049C Process for preparation of citalopram
08/24/2005CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
08/23/2005US6933322 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
08/23/2005US6933309 Halogenobenzyl aminopropionic acid derivatives
08/18/2005WO2005075435A1 Modulators of atp-binding cassette transporters
08/18/2005WO2005063742A3 Amidino compounds as cysteine protease inhibitors
08/18/2005WO2004100873A3 Compounds, compositions, and methods
08/18/2005US20050181948 For controlling phytopathogenic harmful fungi, mildew; (2Z)-N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methyl-2-[5-(trifluoromethyl)-2-pyridinyl]-2-pentenamide
08/18/2005DE10360525B3 Verfahren zur Herstellung von substituierten 2-(Phenoxymethyl)-benzoesäuren Benzoic acids A process for the preparation of substituted 2- (phenoxymethyl)
08/18/2005CA2554796A1 Modulators of atp-binding cassette transporters
08/17/2005EP1562916A1 Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1280757B1 New gamma selective retinoids
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005CN1656083A Novel heterocyclic compounds having antibacterial activity; process for their preparation and pharmaceutical compositions containing them
08/17/2005CN1656058A Amide derivatives as inhibitors of the enzymatic activity of renin
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/17/2005CN1215047C Method for preparing oxazoline catalyzed by metallic salt and method for preparing chloroone therefrom
08/16/2005US6930120 Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists
08/16/2005US6930111 Substituted heterocyclic compounds
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004056315A3 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176966 Process for the preparation of pyrimidine derivative, intermediate therefor and process for the preparation thereof
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176791 5-HT2B receptor antagonists
08/11/2005US20050176789 Modulators of ATP-Binding Cassette transporters
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005US20050175867 Room-temperature molten salt, process for producing the same and applications thereof
08/10/2005EP1383754A4 Process for making taxane derivatives
08/10/2005EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1653025A NK1 antagonists
08/09/2005US6927229 Difluorothioacetamides of oxazolidinones as antibacterial agents
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/04/2005WO2005070907A1 Cyclic diamine compound and pharmaceutical containing the same
08/04/2005WO2005070906A1 Organic compounds
08/04/2005WO2005070905A1 Antidiabetic oxazolidinediones and thiazolidinediones
08/04/2005WO2005070904A2 Sulfonamide compounds and methods of making and using the same
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005030700A3 Amino acids with affinity for the alpha2delta-protein
08/04/2005US20050171205 Process for the preparation of substituted 2-(phenoxymethyl) benzoic acids
08/04/2005US20050171170 Clean, high-yield preparation of S,S and R,S amino acid isosteres
08/04/2005US20050171166 Use as inhibitors of FK560 binding proteins (FKBPs) enzyme activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injury or other related diseases
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171104 Novel thyroid receptor ligands
08/04/2005US20050171102 Semicarbazide derivatives for combating thromboembolic diseases
08/04/2005US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile
08/04/2005CA2553405A1 Antidiabetic oxazolidinediones and thiazolidinediones
08/04/2005CA2553009A1 Organic compounds
08/03/2005EP1558568A1 Nitroaniline-based alkylating agents and their use as prodrugs
08/03/2005EP1558260A2 Quinazolinone compounds as calcilytics
08/03/2005EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
08/03/2005CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649829A Novel florfenicol-type antibiotics
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 210